1. [Home](https://www.g2.com/)
2. ...
3. [Data Science and Machine Learning Platforms](https://www.g2.com/categories/data-science-and-machine-learning-platforms)
4. [Maven Bio Discussions](https://www.g2.com/products/maven-bio/discuss)

[
 ![Maven Bio](https://images.g2crowd.com/uploads/product/image/large_detail/large_detail_6235c6a83347260135e2b0156a866ab4/maven-bio.jpg "Maven Bio")
](/products/maven-bio/reviews)

# Maven Bio Discussions

Maven Bio is a live intelligence platform that helps biopharma teams monitor industry developments and keep the documents behind their decisions current. Teams use Maven to build and maintain competitive views, asset screens, portfolio briefs, and target product profile benchmarks. They define the assets, markets, and questions they care about. Maven monitors new evidence against those priorities, delivers relevant signals, and updates their documents, with sources attached and the option to roll back changes. Maven's global live intelligence layer runs thousands of monitors across company and individual product websites, trade press, health technology assessment bodies, and patient advocacy groups. It brings changes from these distributed sources together with regulatory updates, trial records, financial disclosures, scientific publications, and conference abstracts. Key capabilities include: - Monitor industry developments against each team’s priorities. - Edit and update files automatically, with source citations and the option to roll back changes. - Connect evidence across drugs, companies, trials, and deals. - Access Maven’s intelligence through its application, AI connectors, and API. That intelligence supports work in the Maven application and in the AI tools teams already use. Through connectors and an API, teams can combine Maven's evidence with their internal knowledge and workflows to power research, monitoring, and recurring deliverables. Maven serves business development, competitive intelligence, portfolio strategy, market access, and new product planning teams in biopharma, as well as life sciences consultants and investors. For example, business development teams can monitor shortlisted assets, while competitive intelligence teams track competitor programs across a therapeutic area. Strategy teams can use the resulting evidence to update portfolio assessments as competitor programs advance or fall away.

## Be the first to start the conversation

Get answers from real professionals in the G2 community.